Letter to the shareholdersWe would like to use this opportunity to inform you that we have now started the human clinical safety trial in UK and the first patients are now enrolled. Read morePress and MediaPost not marked as liked
We would like to use this opportunity to inform you that we have now started the human clinical safety trial in UK and the first patients are now enrolled. Read more
